Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2025, vol. 34, nr 11, November, p. 1863–1879

doi: 10.17219/acem/199321

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Wu X, Liu H, Cui L, Mo M, Li C. Genetically determined thyroid function and cerebral cortex structure: A Mendelian randomization study. Adv Clin Exp Med. 2025;34(11):1863–1879. doi:10.17219/acem/199321

Genetically determined thyroid function and cerebral cortex structure: A Mendelian randomization study

Xupeng Wu1,2,A, Hong Liu2,A, Liangliang Cui2,B, Mengyan Mo2,C, Changxin Li1,D,E,F

1 Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China

2 Department of Neurology, Peace Hospital affiliated to Changzhi Medical College, China

Graphical abstract


Graphical abstracts

Highlights


• Thyroid hormones (THs) play an essential role in regulating the development and differentiation of neurons and neuroglia, alongside the overall development and functionality of the central nervous system (CNS).
• A relationship between thyroid function and cognitive impairment has been noted; however, the effects of thyroid dysfunction on alterations in brain cortex structure remain to be explored.
• Researchers can visualize psychiatric diseases and cognitive decline by modifying cerebral cortex anatomy. Thus, various research have examined how thyroid function affects cerebral cortex structure.
• Mendelian randomization (MR) techniques were developed to determine the potential relationship between genetically influenced exposures and clinical outcomes.
• Our findings indicate a possible causal link between thyroid function and the cortical architecture of particular functional areas associated with neurodegenerative and psychiatric conditions.

Abstract

Background. A correlation between thyroid function and cognitive impairment has been well established; however, the impact of thyroid dysfunction on structural changes in the brain cortex remains largely unexplored.

Objectives. The study describes a 2-sample Mendelian randomization (MR) analysis to elucidate the relationship between thyroid malfunction and brain structure and function.

Materials and methods. Eight phenotypes of thyroid function were extracted from THYROIDOMICS consortium by determining free thyroxine (FT4) and thyroid-stimulating hormone (TSH) levels in both men and women separately and together, as well as in individuals with increased or decreased TSH levels. The results were assessed in terms of overall brain cortical thickness and the surface area (SA) of grey matter, along with 34 specific measurements for various regions. The primary method employed for the analysis was the inverse-variance weighted (IVW) approach.

Results. The data were subjected to MR Egger regression, Cochrane’s Q statistic and leave-one-out analysis to determine the correlation between the variables. The FT4 in men, women and overall was statistically associated with cortical thickness of entorhinal cortex (EC). Overall TSH and TSH in men were associated with cortical thickness of caudal anterior cingulate. Additionally, in men, TSH levels showed an association with cortical thickness in the cuneus gyrus. Increased TSH was associated with decreased SA of lateral occipital (LO) and increased SA of lateral orbitofrontal, medial orbitofrontal and superior frontal cortex. Decreased TSH was negatively associated with the SA of pars opercularis (PO) and the cortical thickness of posterior cingulate cortex. No pleiotropy was detected.

Conclusions. Our findings indicate a possible causal link between thyroid function and the cortical architecture of particular functional areas associated with neurodegenerative and psychiatric conditions.

Key words: cognitive function, thyroid function, Mendelian randomization, cerebral cortex structure, psychological diseases

Background

The central nervous system (CNS) and the endocrine system are inextricably connected. Thyroid hormones (THs) are critical for the regulation of the development and differentiation of neurons and neuroglia, as well as the development and function of the CNS. Tri-iodothyronine (T3) stimulates the nervous system, enabling vigilance, wakefulness and responsiveness to external stimuli. Moreover, TH stimulates the peripheral nervous system, enhancing gastrointestinal tone, motility and peripheral reflexes. Neurological impairments and psychiatric abnormalities can result from aberrant TH levels, which are essential for the maintenance of normal brain functions.1, 2 Emerging evidence suggests a potential causal relationship between TH regulation and specific cortical structures, providing novel insights into the neurobiological mechanisms underlying the cognitive and psychiatric manifestations of thyroid dysfunction. This association has significant implications for understanding the pathophysiology of conditions like hypothyroidism-induced depression and cognitive impairment, informing novel therapeutic strategies.3 The relationships between thyroid function and specific cortical structures may be mediated by neural substrates involving the hypothalamic–pituitary–thyroid axis, influencing neuroplasticity and synaptic pruning. Key regions include the hippocampus, amygdala and prefrontal cortex, where THs regulate gene expression, neurotrophic factors and neurotransmitter modulation, impacting cognitive and emotional processing.4 Patients with hypothyroidism frequently experience neurological and psychiatric symptoms, such as mood disorders, impaired memory and lack of concentration.5 Untreated long-term hypothyroidism can cause peripheral neuropathy. Hyperthyroidism can induce various neuropsychiatric symptoms, including anxiety, restlessness, mood instability, insomnia, memory loss, and psychosis.6, 7, 8, 9 Moreover, cognitive decline can occur due to variations in serum TH levels, even within the reference range.10, 11, 12

By altering the structure of the cerebral cortex, it is possible to visualize psychiatric disorders and cognitive decline.13, 14 Consequently, numerous studies have documented the impact of thyroid function on the structural characteristics of the cerebral cortex. For instance, investigations have indicated that subclinical hypothyroidism notably decreases the gray matter volume (GMV) in several brain areas, including the orbitofrontal gyrus and right inferior occipital gyrus, which are involved in sensory functions, impulses and learning.15 Su et al. found that the GMV of specific functional regions, such as the right superior frontal gyrus, superior temporal gyrus, medial frontal gyrus, and supplementary motor area, showed notable decreases in patients with untreated hypothyroidism.16

Similarly, Göbel et al. observed changes in GMV in specific brain regions among individuals with hyperthyroidism.17 The condition results in a reduction of GMV in the bilateral hippocampus and para-hippocampal gyrus, left temporal pole and bilateral primary visual cortex.18 Nevertheless, these studies failed to elucidate the directionality of these relationships. Moreover, the studies conducted with a limited sample size present several significant limitations, such as the challenge of determining reverse causality, the presence of potential confounding variables and discrepancies in interpretations. In light of this, it is crucial to investigate the possible causal impacts of thyroid function on the structure of the cerebral cortex. Examining causal effects can aid in pinpointing risk factors and mitigating the occurrence of thyroid disorders linked to neurological or psychological conditions.

Randomized controlled trials have proven to be valuable in exploring causal relationships; nonetheless, they face challenges such as inadequate long-term compliance from participants and several other complications. The examination of various genetic factors for their correlation with particular studies was facilitated by the accessibility of data from extensive genome-wide association studies (GWAS). As a result, methodologies based on Mendelian randomization (MR) were developed to determine the possible interaction between genetically influenced exposures and clinical outcomes. Genetic variations are considered crucial components in these methodologies.19 Marouli et al.20 previously conducted a study utilizing MR to clarify the risk linked to a reduced likelihood of developing Alzheimer’s disease (AD). The findings indicated that individuals with AD showed an elevation in genetically anticipated thyroid-stimulating hormone (TSH) levels, all while remaining within the normal range. A separate MR study indicated that hypothyroidism may lower the risk of developing schizophrenia. Consequently, it was hypothesized that THs could impact cognitive function and mental state by modifying the structure of particular cerebral functional regions.21

Consequently, we utilized the MR method to explore the causal relationships between thyroid function, both within normal and aberrant ranges, and the structure of the cerebral cortex, which includes the global cerebral cortex along with its 34 functional subdivisions.22 The MR method is utilized for its ability to leverage genetic diversity in examining the causal relationship between exposures and outcomes. This approach utilizes genetic variants as natural experiments, randomly distributed during meiosis, which helps to reduce confounding and misinterpretation of results from epidemiological studies. It effectively avoids reverse causation, ensuring that the genetic variations used in these studies are not influenced by the onset or progression of outcomes. This method provides unbiased estimates of the effects of a causal variable without requiring a traditional randomized controlled trial. As a result, MR is primarily utilized in conjunction with various forms of information for the purpose of causal inference. We investigated single nucleotide polymorphisms (SNPs) to assess whether there is a relationship between an SNP and thyroid function, and how it may influence specific cortical thickness (CT) or surface area (SA) outcomes. After performing a comprehensive literature review, no MR-based study was identified that explored the relationship between cortical thickness, SA of the cerebral cortex and thyroid function phenotypes.

Objectives

This paper presents a 2-sample MR analysis to elucidate the relationship between thyroid dysfunction and brain structure and function.

Materials and methods

Study design and data sources

The guidelines outlined in Strengthening the Reporting of Observational Studies in Epidemiology using MR (STROBE-MR) were followed.23 We accessed the online database (Datasets – The ThyroidOmics Consortium, uni-greifswald.de), which includes GWAS summary data from a meta-analysis conducted by the THYROIDOMICS consortium, to obtain TH measurements. The database includes participants of European ancestry. We analyzed data from 54,288 individuals across 22 independent cohorts for TSH and 49,269 study participants across 19 independent cohorts for free thyroxine (FT4), providing sufficient power (≥80%) to detect small-to-moderate effects (0.1–0.3 standard deviations (SDs)) with a type I error rate of 0.05. The analysis employed MR methods (inverse-variance weighted (IVW), weighted median and MR-Egger regression) and addressed pleiotropy and heterogeneity, ensuring robust estimates of causal relationships. We excluded the data from participants taking thyroid medications or undergoing thyroid surgery. We considered the eligible participants with hormone levels within the cohort-specific reference range to have continuous phenotypes. To gain a comprehensive perspective, we also identified participants with TSH levels exceeding the upper and lower cohort-specific reference ranges, both elevated and decreased, using the summary data.

Assumptions

Three basic assumptions provided the basis of the MR analysis. First, the relevance assumption established a robust correlation between the exposure and the genetic variants. Second, we analyzed the genetic variants to ensure they were not associated with any confounding factors that could influence the exposure–outcome relationship. Finally, we examined the SNPs as genetic variants that influenced the outcome, such as changes in TH levels and/or brain structure, without being affected by alternative pathways. We primarily collected data on normal range thyroid function, as indicated by TSH and FT4 levels, and correlated them with functional regions of the brain. We assessed changes in brain regions by considering variations in cortical thickness and SA. Consequently, we analyzed the causal effects of thyroid dysfunction, specifically hyperthyroidism or hypothyroidism, as indicated by TSH levels, on the cortical structure of 34 distinct brain regions. Figure 1 depicts the overview of this study.

Statistical analyses

Thirty-four specific brain regions were considered as phenotypes. Bonferroni-corrected p-values (i.e., 0.05/544 = 9.192 × 10–5) were used to analyze brain region-level data in 544 MR estimates, accounting for multiple testing. The correlation data were considered significant if the p-value exceeded the Bonferroni-corrected threshold but remained below 0.05. A stronger association between the parameters was declared if the p-value was below 0.01. The study employed Bonferroni correction to adjust for multiple testing, reducing the risk of type I errors. However, the stringent p-value threshold (p < 0.001) may have increased the risk of type II errors in this study, potentially obscuring true associations. For the analysis of changes in cortical regions at the global cortical level, statistical significance was considered if the p-value was < 0.05.

Mendelian randomization analysis

To address pleiotropy, SNPs were selected using thyroid-related GWAS data and proxy SNPs (R2 > 0.8) for index SNPs that had not been explicitly genotyped in this study. The MR methods used were the IVW method for estimating causal effects using SNPs as instruments to account for multiplicative random effects,24 the weighted median method and the MR-Egger regression. In order to mitigate the potential influence of horizontal pleiotropy on IVW estimations, MR-Egger regression was used for analyzing pleiotropy and estimated causal effects, and weighted median, weighted mode and simple mode methods were employed for addressing the potential heterogeneity. The MR-Egger method is commonly employed to detect instances of directional pleiotropy caused by genetic variants. Additionally, it can identify pleiotropic effects that are not associated with genetic variant exposure in general.25 The presence of horizontal pleiotropy was assessed using the weighted median approach. The instrument variables were considered valid if they accounted for more than 50% of the variation.26 The utilization of the weighted mode approach can effectively yield reliable estimates for both valid and invalid cases in general.27

Sensitivity analyses and outlier analyses

Several sensitivity studies were conducted to account for pleiotropy and obtain dependable MR outcomes. The presence of putative directional horizontal pleiotropy was assessed using Merger regression, with a p-value of less than 0.05 for the intercept term.28 The occurrence of pleiotropy was assessed for heterogeneity using Cochran’s Q statistic,25 with a significance level of p < 0.001. In addition, the existence of horizontal pleiotropy (p < 0.001) was assessed using the MR Pleiotropy Residual Sum and Outlier (MR-PRESSO) global tests.29 To assess an outlier, a leave-one out study was conducted. In this analysis, a p-value of less than 0.05 was used to determine if the MR results were significantly influenced by the exclusion of a single SNP.

Assessment of assumptions

For the MR analysis, this study considered the SNP as a genetic instrument. The associations between SNPs and the disorder were included if they exhibited genome-wide significance with p < 0.001 and the same was ascertained by excluding SNPs in linkage disequilibrium (R2 > 0.001 and clump window <10,000 kb). The strength of genetic instruments was determined through F-statistics and SNPs with an F-value <10 were excluded. The data were harmonized, and SNPs with either palindromic or intermediate allele frequencies were excluded, as were outcome-related SNPs that did not meet the genome-wide significance threshold (p ≥ 0.001). To exclude potential bias by risk factors and fulfill the requirements of the 2nd MR hypothesis, the reminding SNPs were searched in the PhenoScanner database.30 The study included 9 possible confounders31, 32, 33, 34, 35, 36, 37, 38: habits of smoking, coffee, and alcohol, diagnosed psychiatric disorders, years of educational attainment, migraine, diagnosed coronary artery diseases, body mass index (BMI), and sleep disorders. The PhenoScanner database revealed that no SNP was associated with migraine, educational attainment, psychiatric disorders, sleep disorders, or coffee intake. However, we identified 1 SNP (rs597808) associated with smoking and cardiovascular diseases, while 3 SNPs (rs1045476, rs4445669 and rs11039355) were linked to BMI. The remaining SNPs were excluded from further analysis due to their lack of direct association with brain structure and related confounders.

Software and data analysis

An online database (https://enigma.ini.usc.edu/research/download-enigma-gwas-results) was browsed and the summary of statistical data from the ENIGMA consortium was downloaded.39 The data on cerebral cortical SA [mm2] and CT [mm] were obtained from a meta-analysis. This GWAS summary data provided access to 51,665 individuals, mainly from the European population (94%). The data were analyzed across 60 cohorts using T1-weighted magnetic resonance imaging (MRI). An additive model was constructed for adjusted routine personal data (including sex, age, their squared values, their interaction, and their squared value), and the genetic associations for each cohort were analyzed. The Desikan–Killiany atlas40 was referred to as state 34 brain regions with known functional specializations. These functional regions of brains were analyzed through the MR approach by using globally weighted estimates and excluding the measures of regional phenotypes. It was carried out to avoid neuroanatomical variability between different individuals in regional phenotypes.

Results

Thyroid function is linked to specific brain regions, impacting neurobiological mechanisms. Hypothyroidism is associated with reduced hippocampal volume, leading to impairments in memory and learning. It affects amygdala activity, altering emotional regulation. Thyroid hormones modulate neurotransmitter balance, impacting cerebral cortex, basal ganglia and cerebellum, influencing mood, cognition and motor function, respectively.

Causal estimation for all brain regions

Initially, 4 indicator SNPs were screened separately for the data related to FT4 of men (FT4_men) and women (FT4_women) prediction while 10 indicator SNPs were analyzed for FT4 overall (FT4_overall). Likewise, 16 indicator SNPs were separately tested for TSH of men (TSH_men) and women (TSH_women) and 25 indicator SNP for overall TSH (TSH_overall). For increased TSH (inc_TSH) and decreased TSH (dec_TSH), 5 and 6 SNPs were included, respectively. As a criterion, the F-statistics of these genetic tools were considered significant if found greater than the normal selection value of 10. The complete results of causal estimation for all brain regions are shown in Figure 1, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6.

Mendelian randomization Egger

Mendelian randomization Egger (MR-Egger) was performed to analyze a directional pleiotropy test, a causal effect test and an estimation of the causal impact assuming that all genetic variants met the primary assumptions. However, the MR-Egger method can determine if genetic variants have pleiotropic effects on the outcome that deviate from 0 on average (directional pleiotropy). Figure 1 displays an analysis of the incTSH_cuneus_SA. Figure 1A depicts a scatter plot that shows the correlation between the effect of SNP on cuneus_SA and its influence on cuneus_TSH. It demonstrates that SNPs influence not only the composition and functionality of the gene product but also its quantity. Meanwhile, Figure 1B presents a forest plot illustrating the results of the MR analysis, which assesses the relationship between cuneus SA (cuneus_SA) and TSH levels (cuneus_TSH). Point estimations are quantified as the alteration in the magnitude of the MR effect size. Figure 1C depicts the funnel plot, which exhibits asymmetry caused by certain genetic variations that have exceptionally powerful influence on the result despite having poor precision. This asymmetry suggests the presence of directional pleiotropy. Figure 1D presents the leave-one-out sensitivity analysis. This method systematically excludes each genetic variant from the MR analysis one at a time to assess the robustness of the results and identify any influential variants that may disproportionately affect the overall findings. Likewise, Figure 2 displays the similar analysis of the incTSH_overall_1 lingual_SA, Figure 3 for incTSH_overall_1 superiorfrontal_thick, Figure 4 displays a research analysis of the thickness of the lateral occipital (LO) region in men, utilizing FT4 data, Figure 5 shows analysis of LO thickness in women with FT4, and Figure 6 presents the study of temporal pole thickness in women with FT4.

The data revealed 7 causal relationships between thyroid function traits and regional cortical thickness, which exhibited nominal statistical significance. Additionally, 5 causal relationships between thyroid function traits and regional cortical SA were observed to be statistically significant. Unfortunately, the study did not find any statistically significant results indicating the impact of thyroid function features on cortical structure in 34 brain functional regions (all p > 0.001). The data showed 7 causal relationships between thyroid functional trait and regional cortical thickness, which were found to have nominal statistical significance while 5 causal relationships between thyroid function traits and regional cortical SA were observed to be statistically significant. However, the impact of thyroid function traits on cortical structure could not be determined in 34 brain functional regions as the results were not statistically significant (all p > 0.001).

The data from the IVW model indicated that, at the functional area level with overall weighted analysis, genetically predicted levels of FT4 in men, women and the overall population were all positively associated with the thickness of the EC. Likewise, for FT4_men and FT4_women, weighted median method was of similar significance. Nonetheless, the consistent direction of association was determined through MR-Egger, simple mode and weighted mode methods. For FT4_overall, the other 4 methods also yielded consistent directions of association with IVW. The data analyzed with overall weighted analysis the IVW model showed that in the functional area level, genetic predicted levels of FT4_men, FT4_women were associated with the thickness of LO sulcus positively with weighted median of similar significance. Moreover, the consistency in the direction of association was strengthened by analysis made through MR-Egger, simple mode and weighted mode methods. Moreover, for another functional area, caudal anterior cingulate cortex (cACC), overall weighted analysis in the IVW model predicted that the level of TSH_overall and TSH_men were separately associated positively with the thickness of this area. For the former, the results were found consistent in the directions of association when analyzed through MR-Egger, weighted median method, simple mode, and weighted mode methods. For the latter, except for MR-Egger, the outcome of other methods affirmed the findings obtained with IVW. The genetic predicted level of TSH_men was also found associated with the thickness of cuneus gyri positively (β (SE): 0.007 (0.004, p = 0.040) through overall weighted analysis by the IVW model. Indeed, the weighted median method and simple mode method yielded consistent directions of association. However, MR-Egger and weighted mode methods obtained opposite directions of association. The data from overall weighted analysis and the IVW model showed that genetic predicted level of FT4_women was associated with the thickness of temporal pole positively. Except for simple mode method, MR-Egger, weighted median method and weighted mode methods supported the directions of association with IVW. The IVW model in the functional area level with overall weighted analysis revealed a reduction in the mean SA of LO (β (SE): –20.246 (8.640), p = 0.019) due to genetic predicted hypothyroidism (inc_TSH) and an increase in the mean SA of lateral orbitofrontal gyri (LOF), medial orbitofrontal gyri (MOF) and superior frontal gyrus (SFG). The consistency in the direction of this association was affirmed by MR-Egger, weighted median method, simple mode, and weighted mode methods. Moreover, the weighted median method also exhibited similar significance for the association of inc_TSH and the SA of MOF. Regarding genetic predicted hyperthyroidism (dec_TSH), the IVW model presented a reduction in the mean SA of PO and the mean thickness of posterior cingulate cortex (PCC). The weighted median method corroborated this significance. The consistency in the data, particular for the directionality of association was affirmed through MR-Egger, simple mode and weighted mode methods. No significant horizontal pleiotropy (all p > 0.05) was detected for the reported significant causalities as was analyzed through MR-Egger intercept test, the MR-PRESSO test and Cochran’s Q test. The leave-one-out analyses also confirmed that no SNP could significantly influence the causal estimates.

Examination of horizontal pleiotropy for 6 distinct outcomes

Table 1 displays the examination of horizontal pleiotropy for 6 distinct outcomes linked to FT4 and TSH levels. The Egger intercept for cuneus_SA was –0.6405, with an standard error (SE) of 2.294 and a p-value of 0.794. The observed residual sum of squares (RSS) for the MR-PRESSO global test was 9.86, with a p-value of 0.293. Additionally, the p-value for Cochran’s Q test was 0.1619. The lingual_SA had an Egger intercept value of –0.1138, with SE of 17.21 and a p-value of 0.665. The observed RSS for the MR-PRESSO global test was 3.134, with a p-value of 0.836. Additionally, the p-value for Cochran’s Q test was 0.0264. The value of the Egger intercept for superior frontal pole thickness was –0.0072, with SE of 0.007 and a p-value of 0.361. The observed RSS for the MR-PRESSO global test was 10.150, with a p-value of 0.223. Additionally, the p-value for Cochran’s Q test was 0.078.

The lateral occipital pole thickness value for men had an Egger intercept of –0.0001 with SE of 0.00106 and a p-value of 0.924. The observed RSS for the MR-PRESSO global test was 2.753 with a p-value of 0.431. Additionally, the p-value for Cochran’s Q test was 0.2546. The lateral occipital pole thickness in women had an Egger intercept of –0.00011, with SE of 0.00104 and a p-value of 0.919. The observed RSS for the MR-PRESSO global test was 7.1135, with a p-value of 0.491. Additionally, the p-value for Cochran’s Q test was 0.29154. The temporal pole thickness in women had an Egger intercept value of –0.00349, with SE of 0.00267 and a p-value of 0.324. The observed RSS for the MR-PRESSO global test was 10.542, with a p-value of 0.413. Additionally, the p-value for Cochran’s Q test was 0.634.

R2_F statistics for single nucleotide polymorphisms

Table 2 presents the R2_F statistics for various SNPs associated with 6 different outcomes related to FT4 and TSH levels. The IVW test computed odds ratios (ORs) for different brain regions (Table 3). The estimated OR for cuneus_SA was 1.147 (with a 95% confidence interval (95% CI) of 1.045–1.457) and a p-value of 0.008. The OR for lingual_SA was calculated to be 1.124 (95% CI: 1.027–1.241), and the p-value associated with this finding was 0.003. The OR for superior frontal thickness was 1.054 (1.004–1.147), and the p-value was 0.002. The OR for lateral occipital _ thickness in men was found to be 1.122 (1.031–1.234), with a p-value of 0.001. The OR for lateral occipital thickness in women was found to be 1.078 (1.005–1.161), accompanied by a p-value of 0.003. Finally, for women, the OR for temporal pole thickness was 1.114 (1.031–1.248) with a p-value of 0.001. Cochran’s Q-test was utilized to assess horizontal multiplicity and to obtain more robust association estimates. The analysis revealed no evidence of horizontal multiplicity, as all p-values for the MR-Egger intercept test exceeded 0.05. Indeed, all p-values from Cochran’s Q analysis were greater than 0.05.

Leave-one-out analyses

Sensitivity analyses are crucial in MR studies to assess the robustness and reliability of causal estimates, identifying potential biases, outliers or assumption violations. These analyses, including leave-one-out, influence, bootstrap, and robustness checks, increase confidence in findings and provide insight into underlying biological mechanisms. Sensitivity analyses, particularly leave-one-out tests, revealed that SNP (rs2235544) substantially influenced the MR estimates for FT4_women on temporal pole and LO thickness, as well as FT4_men on LO thickness in this study. Notably, removing this SNP (rs2235544) resolved the causal effects, underscoring the importance of sensitivity analyses in MR studies to identify and address potential outliers and biases. In contrast, other estimates remained robust across all SNPs. Importantly, this study highlights the necessity of rigorous sensitivity testing to ensure reliable causal inference. Moreover, our findings emphasize that normal-range thyroid function does not have a discernible causal effect on global brain cortex thickness or SA, suggesting region-specific effects of THs on brain structure. These results underscore the value of comprehensive sensitivity analyses in MR studies to validate and refine causal relationships.

Our analysis exhibits several notable strengths, ensuring robust and reliable findings. With a substantial sample size, we achieved sufficient statistical power, exceeding 80%, to detect moderate effects. Rigorous multiple testing corrections via Bonferroni adjustment minimized false positives. Leveraging MR, we established causal inference using genetic instruments. Comprehensive sensitivity analyses verified the stability of estimates, and our region-specific examination uncovered novel associations between THs effects and brain structure. These methodological strengths collectively enhance confidence in our findings, providing valuable insights into the complex relationship between thyroid function and brain anatomy. The findings of present MR analysis reveal a causal link between thyroid function and cortical structure, impacting cognitive and emotional processing. Thyroid malfunction, particularly hypothyroidism, alters SA and thickness in brain regions responsible for emotional regulation, cognitive processing and sensory processing, underscoring TH crucial role in maintaining optimal brain health.

Discussion

Although certain observational studies indicate a potential link between thyroid function and the structure of the cerebral cortex, the definitive causal relationship remains to be determined. The advent of GWAS data has enabled the analysis of genetic factors for their potential links to alterations in brain structure, psychological disorders and TH levels. Recent studies indicate that hypothyroidism may lead to a reduction in gray matter; however, there is still no thorough analysis on this subject.41, 42 This report represents a pioneering investigation that employs MR to elucidate the data concerning the causal relationship between thyroid function and the structure of the cerebral cortex. This includes 34 cortical regions regarding SA and thickness. The findings indicate that the TH or SA of the cortex in particular brain regions linked to cognitive and psychological functions is affected by the characteristics of thyroid function, with no evidence of pleiotropy or heterogeneity.

The entorhinal cortex (EC), situated in the medial temporal lobe, is primarily associated with the regulation of episodic memory; however, its role encompasses functions that go beyond merely facilitating spatial navigation.43 The stimulation has a beneficial impact on memory and learning processes.44

This study investigated a gender-independent positive correlation between FT4 and the thickness of the EC within the normal reference range, suggesting that THs plays a critical role in a variety of brain functions. The influence of AD on EC has been documented in the preclinical stages of the disease.45, 46, 47 Meanwhile; thyroid function has been identified as a critical factor in the pathological progression of AD even within the normal range. Consequently, it is possible to infer that the modulation of EC thickness by THs has an impact on cognitive functions that are involved in the onset and progression of AD.48

The cACC serves as a vital neural structure located in the medial prefrontal cortex and plays a significant role in cognitive control, goal-directed cognition and emotional responses.49 Consequently, the discovery of a positive correlation between the TH of the cACC and the level of TSH_men holds considerable importance.49 Research has identified a diminished cACC volume in both schizophrenia and autism spectrum disorder (ASD). Consequently, further investigation is essential to clarify the specific role of elevated TSH levels within the normal range in alleviating the symptoms associated with ASD, schizophrenia and depression.50, 51

The PCC experiences thinning due to a decrease in TSH (dec_TSH), which plays a crucial role in the encoding of episodic memory and self-spatial orientation.52, 53, 54 The PCC has been linked to numerous psychiatric disorders, including schizophrenia, autism, depression, and attention deficit hyperactivity disorder (ADHD), via metabolic abnormalities, functional connectivity challenges and volumetric atrophy.55, 56, 57, 58, 59, 60 Therefore, it is plausible that the structural atrophy of the PCC could be associated with the psychiatric disorders seen in individuals with hyperthyroidism.

The observation in this study that inc_TSH results in an increase in the SA of the cortical region of the SFG without a significant impact on its thickness is incongruous with observational studies that have reported a decrease in the volume of the SFG in such patients. The superior frontal gyrus, which is situated in the upper portion of the frontal lobe cortex, is comprised of Brodmann areas 6, 8, 9, and 32.61 It is intricately involved in a variety of cognitive functions and motor control tasks, including attention, working memory, cognitive control, and emotional regulation.62 The SFG also plays a role in psychiatric disorders associated with self-consciousness, introspection and self-awareness.62 However, this observed correlation suggests that the SA of the SFG region may be influenced by genetically predicted hypothyroidism, underscoring the intricate relationship between brain morphology and thyroid function. This study also observed a decrease in the SA of the PO as a result of hypothyroidism, in addition to SFG. The PO is predominantly involved in language production,63 lexical selection, phonological processing, and speech encoding.64, 65, 66 Negative changes in PO have been linked to decreased verbal fluency in individuals experiencing normal aging,67 those with schizophrenia,68 and patients with AD.69 Moreover, the volume of this region is reduced in healthy young individuals exhibiting heightened anxiety levels.70 As a result, this finding suggests that hyperthyroidism could play a role in the deficits observed in advanced language functions and emotional regulation due to a reduction in the TH of the PO.

The medial orbitofrontal cortex (mOFC) and the lateral orbitofrontal cortex (lOFC) are 2 distinct regions of the orbitofrontal cortex (OFC). Our study found that hypothyroidism increased cortical SA in the mOFC and lOFC. Damage to the lOFC can disrupt credit allocation in the value learning process, while damage to the mOFC can impede value-oriented decision-making.71 A recent MR analysis72 that links thyroid function and schizophrenia can also be interpreted as a reduction in the mOFC volume in adolescents at familial risk for schizophrenia. This suggests that hypothyroidism may mitigate the risk of developing schizophrenia. Additionally, the GMV in the lOFC has been reduced in patients with depression,73, 74 including school-aged children.75 Our results indicate a potential inverse relationship between hypothyroidism and depression. In contrast, hypothyroidism has been linked to an elevated incidence of depression in observational studies. As a result, a comprehensive examination is necessary to uncover this correlation. Similarly, patients with obsessive-compulsive disorder, generalized anxiety disorder and ASD have been observed to have expanded OFC SA, reduced mOFC SA and decreased OFC SA, respectively.76, 77, 78, 79 Therefore, comprehending the function of TSH in these conditions would provide a new perspective on the management of these disorders.

In the context of neurodevelopment and neuropsychiatric conditions, the observation made in this study regarding a positive correlation between normal-range TSH levels in men and increased thickness in the cuneus region, while hypothyroidism reduced the SA of the LO cortex, is of particular interest. The cuneus is involved in primary visual processing, which encompasses the interpretation of visual field inputs, face recognition, complex affective expression processing, and visual imagery.80 The LO cortex is essential for the identification of fundamental features of external objects and extends its capabilities to more complex cognitive tasks.81, 82, 83, 84, 85 The LO and cuneus regions have been observed to exhibit reductions in both functional activity and SA in children with ASD.86 Similarly, patients with bipolar disorder show a significant reduction in the bilateral SA of the cuneus.87 In a bidirectional MR study,88 the diminished cuneus thickness was also discovered to be associated with an increased risk of AD. Consequently, the results of the present study have exacerbated a complex yet substantial correlation between thyroid function and the emergence of a variety of neuropsychiatric disorders.

It is important to highlight that our study did not find a relationship between the SA of 34 brain regions or the overall cerebral cortex and normal-range thyroid function. This suggests that thyroid function primarily affects the thickness of the cerebral cortex within the normal reference range. Nonetheless, SA of the cerebral cortex is the main focus when considering hypo- or hyperthyroidism. It is crucial to acknowledge that cortical TH and SA serve as 2 relatively independent morphological indicators within the structure of the cerebral cortex.89 As a result, they are shaped by unique genetic influences and pursue different developmental paths.90 As a result, the same exposure factor might not produce a simultaneous or symmetrical effect on both indicators. There is evidence to suggest that thyroid function may have an impact on cerebral blood flow and metabolism. Hypothyroidism can lead to reduced cerebral blood flow in various areas, such as the cuneus and the anterior cingulate cortex.91 Conversely, metabolic irregularities within the limbic lobe may stem from hyperthyroidism.92 Our MR analysis incorporated stringent quality control protocols, encompassing data cleaning, outlier elimination and validation of genetic instruments. We conducted an evaluation of potential biases via sensitivity analyses, examining for pleiotropy and population stratification. Additionally, we utilized IVW and Egger regression to assess causal estimates, thereby ensuring resilience against horizontal pleiotropy and heterogeneity. The implementation of these measures effectively reduced biases, thereby increasing confidence in our findings and confirming the causal relationships between thyroid function and brain anatomy.

Thyroid hormone influences brain regions by interacting with its receptors in essential areas such as the cingulate gyrus, hippocampus and amygdala.92 An investigation into the human limbic system carried out through autopsy revealed the existence of TSH receptors in neurons.93 This finding suggests that variations in FT4 and TSH levels may influence metabolism in this region, resulting in structural alterations. Thyroid hormones play a crucial role in shaping neural development, differentiation and functionality in areas such as the EC, caudal anterior cingulate and cuneus gyri. They regulate neuroplasticity, synaptic function, and neurotrophic factors, such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), crucial for cognitive processes and emotional regulation. Alterations in TH levels impact neural circuit structure and function, affecting gene expression, axonal growth and synaptic transmission. Thyroid hormones also modulate neurotransmitter systems, including serotonin, dopamine and gamma-aminobutyric acid (GABA), influencing mood and cognition.94, 95, 96, 97

Existing literature emphasizes the importance of THs in neuronal survival, synaptogenesis and neuronal connectivity, shedding light on the mechanisms that explain the noted relationships between thyroid function and brain structure. The relationship between thyroid function and brain structure carries important clinical implications, indicating that thyroid disorders could play a role in neurodegenerative diseases, cognitive decline and mood disorders. Future studies should explore the neuroprotective effects of THs, optimal treatment strategies and biomarkers for early detection.94 Possible clinical applications encompass tailored TH therapy, neuroprotective strategies and innovative approaches for AD, depression and anxiety disorders. Recent MR-based studies have uncovered a link between obesity, sleep disorders and cortical structure. The thickness and SA of certain cortical regions can be affected by these conditions.98, 99 Individuals with hypothyroidism often face an increased risk of obesity and sleep disorders.100 Therefore, it is essential to conduct additional inquiries into the interactive effects of these factors. Future studies on genetically determined thyroid function and cerebral cortex structure should concentrate on exploring the mechanisms that influence the effects of THs on neurogenesis, synaptogenesis and neuronal plasticity. Furthermore, investigating connections with cognitive decline, mood disorders and neurodegenerative diseases will be essential. Longitudinal studies will investigate the impact of thyroid function on brain development and maturation, while genetic and epigenetic analyses will assist in identifying regulatory variants. Investigations will also focus on therapeutic strategies, including hormone supplementation, for addressing thyroid-related brain health issues. Through the integration of knowledge from various fields such as endocrinology, neuroscience, genetics and epidemiology, these studies seek to clarify intricate relationships and enhance clinical practice, with the ultimate goal of advancing brain health outcomes.

Limitations

This investigation is subject to certain limitations. Primarily, the GWAS data used in this research was derived from European populations. Consequently, the applicability of these findings to other ethnic groups should be approached with caution. Second, the absence of age information in the GWAS data is a significant limitation, as age is a crucial factor influencing both thyroid function and brain structure. Furthermore, the objective of this investigation was to investigate the causal relationship between thyroid function and cortical structure by employing specific metrics, including volume, thickness, SA, and gyrification index. A broader array of indicators could be incorporated into comprehensive studies to further investigate the correlation between brain structure and thyroid function. However, these approaches have certain limitations as well such as MR-Egger assumes instrumental variable independence, potentially leading to biased estimates if pleiotropy exists. Similarly, weighted median methods can be sensitive to outliers and may not perform well with weak instruments or non-causal associations. Additionally, both methods assume linear relationships, potentially masking non-linear effects. Moreover, MR findings should be interpreted cautiously due to limitations, including potential unmeasured confounding variables, pleiotropy and population stratification. Additionally, MR assumes a linear relationship between genetic variants and outcomes, and instrumental variable validity relies on strong assumptions. These limitations may bias or distort causal estimates. It is important to consider the possibility that the exposed and outcome groups may overlap in the 2-sample MR analysis. This overlap could introduce bias into the results, potentially affecting the conclusions.

Conclusions

This innovative MR analysis investigated the causal relationship between thyroid function and cortical structure. The results demonstrate that thyroid dysfunction, especially hypothyroidism, affects the SA of various cortical regions linked to mental and emotional processing. Moreover, optimal thyroid function significantly impacts the thickness of brain regions intricately linked to cognitive function, including the EC. This study provides new evidence that highlights the link between thyroid function and cognitive abilities, along with mental and psychological health. Furthermore, it offers valuable insights into improving the management of related conditions. However, additional studies are needed to validate the relationship between thyroid function and brain structure.

Ethics statement

The dataset mentioned above were all publicly available. The corresponding inform consents from participants were received in the original research. Thus, no ethics was required for our study.

Data availability statement

The thyroid function datasets studied in this study are accessible through the GWAS Public database (Datasets – The ThyroidOmics Consortium (https://www.uni-greifswald.de)). The datasets evaluated in the current study of the human cerebral cortex are available on the ENIGMA Consortium website (https://enigma.ini.usc.edu/research/download-enigma-gwas-results).

Consent for publication

Not applicable.

Use of AI and AI-assisted technologies

Not applicable.

Tables


Table 1. Horizontal pleiotropy analysis for 6 different outcomes associated with FT4 and TSH levels

Exposure

Outcome

MR-Egger intercept test

MR-PRESSO global test

Cochran’s Q

Egger intercept

SE

p-value

RSS obs

p-value

p-value

inc_TSH

cuneus_sa

cuneus_SA

–0.6405

2.294

0.7939

9.865

0.293

0.162

incTSH_overall_1

lingual_SA

–0.1138

17.21

0.9950

3.134

0.836

0.026

incTSH_overall_1

superiorfrontal_thick

–0.0072

0.0070

0.3609

10.510

0.223

0.078

FT4_men

lateraloccipital_thick

0.0001

0.00106

0.9239

2.753

0.4314

0.255

FT4_women

lateraloccipital_thick

–0.00011

0.00104

0.9192

7.1135

0.491

0.292

FT4_women

temporalpole-thick

–0.00349

0.00267

0.3236

10.542

0.413

0.634

TSH – thyroid-stimulating hormone; SA – surface area; FT4 – free thyroxine; SE – standard error; RSS – residual sum of squares.
Table 2. R2_F statistics of different SNPs of 6 different outcomes associated with FT4 and TSH levels

SNP

effect_allele.exposure

other_allele.exposure

eaf.exposure

beta.exposure

se.
exposure

pval.exposure

samplesize.exposure

R2

F-value

inc_TSH & cuneus_SA

rs11675342

T

C

0.3988

0.1604

0.025

1.48E–10

53241

0.012337

665.0189

rs12449792

T

C

0.3168

0.1566

0.0281

2.41E–08

46314

0.010616

496.9069

rs143344027

A

G

0.9881

–0.5314

0.0827

1.33E–10

53241

0.006641

355.9136

rs597808

A

G

0.2253

0.1801

0.0259

3.47E–12

53241

0.011323

609.7159

rs75491569

T

C

0.1777

–0.2384

0.0367

8.67E–11

53241

0.01661

899.2163

rs78495697

T

C

0.1424

0.3157

0.0414

2.56E–14

53241

0.024343

1328.332

inc_TSH lingual_SA

rs11675342

T

C

0.3988

0.1604

0.025

1.48E–10

53241

0.012337

665.0189

rs12449792

T

C

0.3168

0.1566

0.0281

2.41E–08

46314

0.010616

496.9069

rs143344027

A

G

0.9881

–0.5314

0.0827

1.33E–10

53241

0.006641

355.9136

rs597808

A

G

0.2253

0.1801

0.0259

3.47E–12

53241

0.011323

609.7159

rs75491569

T

C

0.1777

–0.2384

0.0367

8.67E–11

53241

0.01661

899.2163

rs78495697

T

C

0.1424

0.3157

0.0414

2.56E–14

53241

0.024343

1328.332

inc_TSH & SFG_TH

rs11675342

T

C

0.3988

0.1604

0.025

1.48E–10

53241

0.012337

665.0189

rs12449792

T

C

0.3168

0.1566

0.0281

2.41E–08

46314

0.010616

496.9069

rs143344027

A

G

0.9881

–0.5314

0.0827

1.33E–10

53241

0.006641

355.9136

rs597808

A

G

0.2253

0.1801

0.0259

3.47E–12

53241

0.011323

609.7159

rs75491569

T

C

0.1777

–0.2384

0.0367

8.67E–11

53241

0.01661

899.2163

rs78495697

T

C

0.1424

0.3157

0.0414

2.56E–14

53241

0.024343

1328.332

FT4_men&LO_TH

rs113107469

T

C

0.01465

0.2127

0.0322

4.07E–11

22455

0.001306

29.36535

rs11626434

C

G

0.3741

0.058

0.0102

1.23E–08

22455

0.001575

35.42727

rs1388385

A

G

0.3118

–0.0588

0.0102

7.16E–09

22455

0.001484

33.36527

rs2235544

A

C

0.4432

0.1388

0.0095

5.86E–48

22455

0.009508

215.5418

FT4_women&LO_TH

rs113107469

T

C

0.01465

0.1784

0.0294

1.35E–09

27380

0.000919

25.1796

rs2235544

A

C

0.4432

0.138

0.0087

8.23E–57

27380

0.009399

259.7707

rs225014

T

C

0.5788

0.0511

0.009

1.30E–08

27380

0.001273

34.90147

rs7151700

A

C

0.4821

0.059

0.0094

4.05E–10

27380

0.001738

47.67321

FT4_women&TP_TH

rs113107469

T

C

0.01465

0.1784

0.0294

1.35E–09

27380

0.000919

25.1796

rs2235544

A

C

0.4432

0.138

0.0087

8.23E–57

27380

0.009399

259.7707

rs225014

T

C

0.5788

0.0511

0.009

1.30E–08

27380

0.001273

34.90147

rs7151700

A

C

0.4821

0.059

0.0094

4.05E–10

27380

0.001738

47.67321

TSH – thyroid-stimulating hormone; SA – surface area; FT – free thyroxine; SFG-TH – superior frontal gyrus thyroid hormones; LO-TH – lateral occipital thyroid hormones; TP-TH – temporal pole thyroid hormone.
Table 3. Odds ratio (OR) of 6 different outcomes associated with FT4 and TSH levels by inverse variance method

Exposure

Outcome

OR (95% CI)

p-value

inc_TSH cuneus_sa

cuneus_SA

1.147 (1.045–1.457)

0.008

incTSH_overall_1

lingual_SA

1.124 (1.027–1.241)

0.003

incTSH_overall_1

superiorfrontal_thick

1.054 (1.004–1.147)

0.002

FT4_men

lateraloccipital_thick

1.122 (1.031–1.234)

0.001

FT4_women

lateraloccipital_thick

1.078 (1.005–1.161)

0.003

FT4_women

temporalpole_thick

1.114 (1.031–1.248)

0.001

TSH – thyroid-stimulating hormone; SA – surface area; FT– free thyroxine; 95% CI – 95% confidence interval.

Figures


Fig. 1. Analysis of incTSH_cuneus_SA. A. Scatter plot; B. Forest plot; C. Funnel plot; D. Leave-one-out sensitivity analysis
MR – Mendelian randomization; TSH – thyroid-stimulating hormone; SNP – single nucleotide polymorphism.
Fig. 2. Analysis of incTSH_overall_1 lingual_SA. A. Scatter plot; B. Forest plot; C. Funnel plot; D. Leave-one-out sensitivity analysis
MR – Mendelian randomization; TSH – thyroid-stimulating hormone; SNP – single nucleotide polymorphism.
Fig. 3. Analysis of incTSH_overall_1 superiorfrontal_thick. A. Scatter plot; B. Forest plot; C. Funnel plot; D. Leave-one-out sensitivity analysis
MR – Mendelian randomization; TSH – thyroid-stimulating hormone; SNP – single nucleotide polymorphism.
Fig. 4. Analysis of FT4-men lateraloccipital_thick. A. Scatter plot; B. Forest plot; C. Funnel plot; D. Leave-one-out sensitivity analysis
MR – Mendelian randomization; TSH – thyroid-stimulating hormone; SNP – single nucleotide polymorphism.
Fig. 5. Analysis of FT4-women lateraloccipital_ thick. A. Scatter plot; B. Forest plot; C. Funnel plot; D. Leave-one-out sensitivity analysis
MR – Mendelian randomization; TSH – thyroid-stimulating hormone; SNP – single nucleotide polymorphism.
Fig. 6. Analysis of FT4-women temporalpole_thick. A. Scatter plot; B. Forest plot; C. Funnel plot; D. Leave-one-out sensitivity analysis
MR – Mendelian randomization; TSH – thyroid-stimulating hormone; SNP – single nucleotide polymorphism.

References (100)

  1. Liu Y, Brent GA. The role of thyroid hormone in neuronal protection. Compr Physiol. 2021;11(3):2075–2095. doi:10.1002/cphy.c200019
  2. Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008;20(10):1101–1114. doi:10.1111/j.1365-2826.2008.01774.x
  3. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550–1562. doi:10.1016/S0140-6736(17)30703-1
  4. Gold MS, Pottash AL, Extein I. Hypothyroidism and depression: Evidence from complete thyroid function evaluation. JAMA. 1981;245(19):1919–1922. doi:10.1001/jama.245.19.1919
  5. Samuels MH, Bernstein LJ. Brain fog in hypothyroidism: What is it, how is it measured, and what can be done about it. Thyroid. 2022;32(7):752–763. doi:10.1089/thy.2022.0139
  6. Demet MM, Özmen B, Deveci A, Boyvada S, Adıgüzel H, Aydemir Ö. Depression and anxiety in hyperthyroidism. Arch Med Res. 2002;33(6):552–556. doi:10.1016/S0188-4409(02)00410-1
  7. Fardella CE, Gloger S. Neurobehavioral and psychological changes induced by hyperthyroidism: Diagnostic and therapeutic implications. Exp Rev Neurother. 2002;2(5):709–716. doi:10.1586/14737175.2.5.709
  8. Vogel A, Elberling TinaV, Hørding M, et al. Affective symptoms and cognitive functions in the acute phase of Graves’ thyrotoxicosis. Psychoneuroendocrinology. 2007;32(1):36–43. doi:10.1016/j.psyneuen.2006.09.012
  9. Yuan L, Tian Y, Zhang F, et al. Impairment of attention networks in patients with untreated hyperthyroidism. Neurosci Lett. 2014;574:26–30. doi:10.1016/j.neulet.2014.05.016
  10. De Jong FJ, Masaki K, Chen H, et al. Thyroid function, the risk of dementia and neuropathologic changes: The Honolulu–Asia Aging Study. Neurobiol Aging. 2009;30(4):600–606. doi:10.1016/j.neurobiolaging.2007.07.019
  11. Tan ZS, Beiser A, Vasan RS, et al. Thyroid function and the risk of Alzheimer disease: The Framingham Study. Arch Intern Med. 2008;168(14):1514–1520. doi:10.1001/archinte.168.14.1514
  12. Van Osch LADM, Hogervorst E, Combrinck M, Smith AD. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology. 2004;62(11):1967–1971. doi:10.1212/01.WNL.0000128134.84230.9F
  13. Galakhova AA, Hunt S, Wilbers R, et al. Evolution of cortical neurons supporting human cognition. Trends Cogn Sci. 2022;26(11):909–922. doi:10.1016/j.tics.2022.08.012
  14. Guo J, Yu K, Dong SS, et al. Mendelian randomization analyses support causal relationships between brain imaging-derived phenotypes and risk of psychiatric disorders. Nat Neurosci. 2022;25(11):1519–1527. doi:10.1038/s41593-022-01174-7
  15. Zhang Y, Yang Y, Tao B, Lv Q, Lui S, He L. Gray matter and regional brain activity abnormalities in subclinical hypothyroidism. Front Endocrinol (Lausanne). 2021;12:582519. doi:10.3389/fendo.2021.582519
  16. Su W, Zhao L, Bao S, et al. Alterations in gray matter morphology and functional connectivity in adult patients with newly diagnosed untreated hypothyroidism. Thyroid. 2023;33(7):791–803. doi:10.1089/thy.2022.0476
  17. Göbel A, Heldmann M, Göttlich M, Dirk AL, Brabant G, Münte TF. Effect of experimental thyrotoxicosis on brain gray matter: A voxel-based morphometry study. Eur Thyroid J. 2015;4(Suppl 1):113–118. doi:10.1159/000398793
  18. Zhang W, Song L, Yin X, et al. Grey matter abnormalities in untreated hyperthyroidism: A voxel-based morphometry study using the DARTEL approach. Eur J Radiol. 2014;83(1):e43–e48. doi:10.1016/j.ejrad.2013.09.019
  19. Davey Smith G, Hemani G. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–R98. doi:10.1093/hmg/ddu328
  20. Marouli E, Yusuf L, Kjaergaard AD, et al. Thyroid function and the risk of Alzheimer’s disease: A Mendelian randomization study. Thyroid. 2021;31(12):1794–1799. doi:10.1089/thy.2021.0321
  21. Freuer D, Meisinger C. Causal link between thyroid function and schizophrenia: A two-sample Mendelian randomization study. Eur J Epidemiol. 2023;38(10):1081–1088. doi:10.1007/s10654-023-01034-z
  22. Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021;326(16):1614. doi:10.1001/jama.2021.18236
  23. Teumer A, Chaker L, Groeneweg S, et al. Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation. Nat Commun. 2018;9(1):4455. doi:10.1038/s41467-018-06356-1
  24. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–665. doi:10.1002/gepi.21758
  25. Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36(11):1783–1802. doi:10.1002/sim.7221
  26. Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28(1):30–42. doi:10.1097/EDE.0000000000000559
  27. Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–1998. doi:10.1093/ije/dyx102
  28. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–525. doi:10.1093/ije/dyv080
  29. Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–698. doi:10.1038/s41588-018-0099-7
  30. Staley JR, Blackshaw J, Kamat MA, et al. PhenoScanner: A database of human genotype–phenotype associations. Bioinformatics. 2016;32(20):3207–3209. doi:10.1093/bioinformatics/btw373
  31. Ansari D. Culture and education: New frontiers in brain plasticity. Trends Cogn Sci. 2012;16(2):93–95. doi:10.1016/j.tics.2011.11.016
  32. Chen W, Feng J, Guo J, et al. Obesity causally influencing brain cortical structure: A Mendelian randomization study. Cereb Cortex. 2023;33(15):9409–9416. doi:10.1093/cercor/bhad214
  33. Chen Y, Lyu S, Xiao W, Yi S, Liu P, Liu J. Sleep traits causally affect the brain cortical structure: A Mendelian randomization study. Biomedicines. 2023;11(8):2296. doi:10.3390/biomedicines11082296
  34. Wang M, Wang Z, Wang Y, Zhou Q, Wang J. Causal relationships involving brain imaging-derived phenotypes based on UKB imaging cohort: A review of Mendelian randomization studies. Front Neurosci. 2024 Jul 10;18:1436223. doi:10.3389/fnins.2024.1436223
  35. Kang J, Jia T, Jiao Z, et al. Increased brain volume from higher cereal and lower coffee intake: Shared genetic determinants and impacts on cognition and metabolism. Cereb Cortex. 2022;32(22):5163–5174. doi:10.1093/cercor/bhac005
  36. Logtenberg E, Overbeek MF, Pasman JA, et al. Investigating the causal nature of the relationship of subcortical brain volume with smoking and alcohol use. Br J Psychiatry. 2022;221(1):377–385. doi:10.1192/bjp.2021.81
  37. Mitchell BL, Diaz-Torres S, Bivol S, et al. Elucidating the relationship between migraine risk and brain structure using genetic data. Brain. 2022;145(9):3214–3224. doi:10.1093/brain/awac105
  38. Mohanta SK, Yin C, Weber C, et al. Cardiovascular brain circuits. Circ Res. 2023;132(11):1546–1565. doi:10.1161/CIRCRESAHA.123.322791
  39. Grasby KL, Jahanshad N, Painter JN, et al. The genetic architecture of the human cerebral cortex. Science. 2020;367(6484):eaay6690. doi:10.1126/science.aay6690
  40. Chen CH, Fiecas M, Gutiérrez ED, et al. Genetic topography of brain morphology. Proc Natl Acad Sci U S A. 2013;110(42):17089–17094. doi:10.1073/pnas.1308091110
  41. Maass A, Berron D, Libby LA, Ranganath C, Düzel E. Functional subregions of the human entorhinal cortex. eLife. 2015;4:e06426. doi:10.7554/eLife.06426
  42. Kim IB, Park SC. The entorhinal cortex and adult neurogenesis in major depression. Int J Mol Sci. 2021;22(21):11725. doi:10.3390/ijms222111725
  43. Nau M, Navarro Schröder T, Bellmund JLS, Doeller CF. Hexadirectional coding of visual space in human entorhinal cortex. Nat Neurosci. 2018;21(2):188–190. doi:10.1038/s41593-017-0050-8
  44. Kobayashi K, Yoshinaga H, Ohtsuka Y. Memory enhancement and deep-brain stimulation of the entorhinal area. N Engl J Med. 2012;366(20):1945; author reply 1946. doi:10.1056/NEJMc1203204
  45. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259. doi:10.1007/BF00308809
  46. Kaufman SK, Del Tredici K, Thomas TL, Braak H, Diamond MI. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART. Acta Neuropathol. 2018;136(1):57–67. doi:10.1007/s00401-018-1855-6
  47. Yeung LK, Olsen RK, Bild-Enkin HEP, et al. Anterolateral entorhinal cortex volume predicted by altered intra-item configural processing. J Neurosci. 2017;37(22):5527–5538. doi:10.1523/JNEUROSCI.3664-16.2017
  48. Gray JR, Braver TS. Personality predicts working-memory-related activation in the caudal anterior cingulate cortex. Cogn Affect Behav Neurosci. 2002;2(1):64–75. doi:10.3758/CABN.2.1.64
  49. Yuan Q, Liang X, Xue C, et al. Altered anterior cingulate cortex subregional connectivity associated with cognitions for distinguishing the spectrum of pre-clinical Alzheimer’s disease. Front Aging Neurosci. 2022;14:1035746. doi:10.3389/fnagi.2022.1035746
  50. Choi JS, Kang DH, Kim JJ, et al. Decreased caudal anterior cingulate gyrus volume and positive symptoms in schizophrenia. Psychiatry Res Neuroimaging. 2005;139(3):239–247. doi:10.1016/j.pscychresns.2004.05.008
  51. Laidi C, Boisgontier J, De Pierrefeu A, et al. Decreased cortical thickness in the anterior cingulate cortex in adults with autism. J Autism Dev Disord. 2019;49(4):1402–1409. doi:10.1007/s10803-018-3807-3
  52. Guterstam A, Björnsdotter M, Gentile G, Ehrsson HH. Posterior cingulate cortex integrates the senses of self-location and body ownership. Curr Biol. 2015;25(11):1416–1425. doi:10.1016/j.cub.2015.03.059
  53. Natu VS, Lin JJ, Burks A, Arora A, Rugg MD, Lega B. Stimulation of the posterior cingulate cortex impairs episodic memory encoding. J Neurosci. 2019;39(36):7173–7182. doi:10.1523/JNEUROSCI.0698-19.2019
  54. Rolls ET, Cheng W, Feng J. The orbitofrontal cortex: Reward, emotion and depression. Brain Commun. 2020;2(2):fcaa196. doi:10.1093/braincomms/fcaa196
  55. Byun MS, Kim JS, Jung WH, et al. Regional cortical thinning in subjects with high genetic loading for schizophrenia. Schizophr Res. 2012;141(2–3):197–203. doi:10.1016/j.schres.2012.08.028
  56. Leech R, Sharp DJ. The role of the posterior cingulate cortex in cognition and disease. Brain. 2014;137(1):12–32. doi:10.1093/brain/awt162
  57. Narr KL, Toga AW, Szeszko P, et al. Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol Psychiatry. 2005;58(1):32–40. doi:10.1016/j.biopsych.2005.03.043
  58. Outen JD, Burhanullah MH, Vandrey R, et al. Cannabinoids for agitation in Alzheimer’s disease. Am J Geriatr Psychiatry. 2021;29(12):1253–1263. doi:10.1016/j.jagp.2021.01.015
  59. Ries ML, Wichmann A, Bendlin BB, Johnson SC. Posterior cingulate and lateral parietal gray matter volume in older adults with depressive symptoms. Brain Imaging Behav. 2009;3(3):233–239. doi:10.1007/s11682-009-9065-4
  60. Zhou C, Xu J, Ping L, et al. Cortical thickness and white matter integrity abnormalities in obsessive-compulsive disorder: A combined multimodal surface-based morphometry and tract-based spatial statistics study. Depress Anxiety. 2018;35(8):742–751. doi:10.1002/da.22758
  61. Kraljević N, Schaare HL, Eickhoff SB, et al. Behavioral, anatomical and heritable convergence of affect and cognition in superior frontal cortex. NeuroImage. 2021;243:118561. doi:10.1016/j.neuroimage.2021.118561
  62. Li W, Qin W, Liu H, et al. Subregions of the human superior frontal gyrus and their connections. NeuroImage. 2013;78:46–58. doi:10.1016/j.neuroimage.2013.04.011
  63. Tomaiuolo F, MacDonald JD, Caramanos Z, et al. Morphology, morphometry and probability mapping of the pars opercularis of the inferior frontal gyrus: An in vivo MRI analysis. Eur J Neurosci. 1999;11(9):3033–3046. doi:10.1046/j.1460-9568.1999.00718.x
  64. Costafreda SG, Fu CHY, Lee L, Everitt B, Brammer MJ, David AS. A systematic review and quantitative appraisal of fMRI studies of verbal fluency: Role of the left inferior frontal gyrus. Hum Brain Mapp. 2006;27(10):799–810. doi:10.1002/hbm.20221
  65. Papoutsi M, De Zwart JA, Jansma JM, Pickering MJ, Bednar JA, Horwitz B. From phonemes to articulatory codes: An fMRI study of the role of Broca’s area in speech production. Cereb Cortex. 2009;19(9):2156–2165. doi:10.1093/cercor/bhn239
  66. Schnur TT, Schwartz MF, Kimberg DY, Hirshorn E, Coslett HB, Thompson-Schill SL. Localizing interference during naming: Convergent neuroimaging and neuropsychological evidence for the function of Broca’s area. Proc Natl Acad Sci U S A. 2009;106(1):322–327. doi:10.1073/pnas.0805874106
  67. Vonk JMJ, Rizvi B, Lao PJ, et al. Letter and category fluency performance correlates with distinct patterns of cortical thickness in older adults. Cereb Cortex. 2019;29(6):2694–2700. doi:10.1093/cercor/bhy138
  68. North HF, Bruggemann J, Cropley V, et al. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatry Clin Neurosci. 2021;271(4):595–607. doi:10.1007/s00406-021-01237-z
  69. Yang A, Du L, Gao W, et al. Associations of cortical iron accumulation with cognition and cerebral atrophy in Alzheimer’s disease. Quant Imaging Med Surg. 2022;12(9):4570–4586. doi:10.21037/qims-22-7
  70. Hu Y, Dolcos S. Trait anxiety mediates the link between inferior frontal cortex volume and negative affective bias in healthy adults. Soc Cogn Affect Neurosci. 2017;12(5):775–782. doi:10.1093/scan/nsx008
  71. Noonan MP, Chau BKH, Rushworth MFS, Fellows LK. Contrasting effects of medial and lateral orbitofrontal cortex lesions on credit assignment and decision-making in humans. J Neurosci. 2017;37(29):7023–7035. doi:10.1523/JNEUROSCI.0692-17.2017
  72. Jiang QH, Gong WD. Correlation analyse between thyroid hormone levels and severity of schizophrenia symptoms. World J Psychiatry. 2025;15(1):100880. doi:10.5498/wjp.v15.i1.100880
  73. Grieve SM, Korgaonkar MS, Koslow SH, Gordon E, Williams LM. Widespread reductions in gray matter volume in depression. NeuroImage Clin. 2013;3:332–339. doi:10.1016/j.nicl.2013.08.016
  74. Price JL, Drevets WC. Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci. 2012;16(1):61–71. doi:10.1016/j.tics.2011.12.011
  75. Fowler CH, Gaffrey MS. Reduced cortical surface area globally and in reward-related cortex is associated with elevated depressive symptoms in preschoolers. J Affect Disord. 2022;319:286–293. doi:10.1016/j.jad.2022.09.075
  76. Ecker C, Ginestet C, Feng Y, et al. Brain surface anatomy in adults with autism: The relationship between surface area, cortical thickness, and autistic symptoms. JAMA Psychiatry. 2013;70(1):59. doi:10.1001/jamapsychiatry.2013.265
  77. Hirjak D, Kubera KM, Northoff G, et al. Cortical contributions to distinct symptom dimensions of catatonia. Schizophr Bull. 2019;45(6):1184–1194. doi:10.1093/schbul/sby192
  78. Rus OG, Reess TJ, Wagner G, Zaudig M, Zimmer C, Koch K. Structural alterations in patients with obsessive–compulsive disorder: A surface-based analysis of cortical volume, surface area and thickness. J Psychiatry Neurosci. 2017;42(6):395–403. doi:10.1503/jpn.170030
  79. Zhang T, Xie X, Li Q, et al. Hypogyrification in generalized anxiety disorder and associated with insomnia symptoms. Nat Sci Sleep. 2022;14:1009–1019. doi:10.2147/NSS.S358763
  80. Palejwala AH, Dadario NB, Young IM, et al. Anatomy and white matter connections of the lingual gyrus and cuneus. World Neurosurg. 2021;151:e426–e437. doi:10.1016/j.wneu.2021.04.050
  81. Cattaneo Z, Lega C, Ferrari C, et al. The role of the lateral occipital cortex in aesthetic appreciation of representational and abstract paintings: A TMS study. Brain Cogn. 2015;95:44–53. doi:10.1016/j.bandc.2015.01.008
  82. Grill-Spector K, Kourtzi Z, Kanwisher N. The lateral occipital complex and its role in object recognition. Vision Res. 2001;41(10–11):1409–1422. doi:10.1016/S0042-6989(01)00073-6
  83. Gschwind M, Pourtois G, Schwartz S, Van De Ville D, Vuilleumier P. White-matter connectivity between face-responsive regions in the human brain. Cereb Cortex. 2012;22(7):1564–1576. doi:10.1093/cercor/bhr226
  84. Guo D, Yang J. Reactivation of schema representation in lateral occipital cortex supports successful memory encoding. Cereb Cortex. 2023;33(10):5968–5980. doi:10.1093/cercor/bhac475
  85. Libero LE, Maximo JO, Deshpande HD, Klinger LG, Klinger MR, Kana RK. The role of mirroring and mentalizing networks in mediating action intentions in autism. Mol Autism. 2014;5(1):50. doi:10.1186/2040-2392-5-50
  86. Jung M, Tu Y, Lang CA, et al. Decreased structural connectivity and resting-state brain activity in the lateral occipital cortex is associated with social communication deficits in boys with autism spectrum disorder. NeuroImage. 2019;190:205–212. doi:10.1016/j.neuroimage.2017.09.031
  87. Achalia R, Raju VB, Jacob A, et al. Comparison of first-episode and multiple-episode bipolar disorder: A surface-based morphometry study. Psychiatry Res Neuroimaging. 2020;302:111110. doi:10.1016/j.pscychresns.2020.111110
  88. Seyedsalehi A, Warrier V, Bethlehem RAI, Perry BI, Burgess S, Murray GK. Educational attainment, structural brain reserve and Alzheimer’s disease: A Mendelian randomization analysis. Brain. 2023;146(5):2059–2074. doi:10.1093/brain/awac392
  89. Panizzon MS, Fennema-Notestine C, Eyler LT, et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex. 2009;19(11):2728–2735. doi:10.1093/cercor/bhp026
  90. Wierenga LM, Langen M, Oranje B, Durston S. Unique developmental trajectories of cortical thickness and surface area. NeuroImage. 2014;87:120–126. doi:10.1016/j.neuroimage.2013.11.010
  91. Haji M, Kimura N, Hanaoka T, et al. Evaluation of regional cerebral blood flow in Alzheimer’s disease patients with subclinical hypothyroidism. Dement Geriatr Cogn Disord. 2015;39(5–6):360–367. doi:10.1159/000375298
  92. Schreckenberger MF, Egle UT, Drecker S, et al. Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J Clin Endocrinol Metab. 2006;91(12):4786–4791. doi:10.1210/jc.2006-0573
  93. Naicker M, Naidoo S. Expression of thyroid-stimulating hormone receptors and thyroglobulin in limbic regions in the adult human brain. Metab Brain Dis. 2018;33(2):481–489. doi:10.1007/s11011-017-0076-3
  94. Battaglia S, Nazzi C, Lonsdorf TB, Thayer JF. Neuropsychobiology of fear-induced bradycardia in humans: Progress and pitfalls. Mol Psychiatry. 2024;29(12):3826–3840. doi:10.1038/s41380-024-02600-x
  95. Battaglia S, Nazzi C, Fullana MA, Di Pellegrino G, Borgomaneri S. ‘Nip it in the bud’: Low-frequency rTMS of the prefrontal cortex disrupts threat memory consolidation in humans. Behav Res Ther. 2024;178:104548. doi:10.1016/j.brat.2024.104548
  96. Tanaka M, Tuka B, Vécsei L. Navigating the neurobiology of migraine: From pathways to potential therapies. Cells. 2024;13(13):1098. doi:10.3390/cells13131098
  97. Tanaka M, Vécsei L. A decade of dedication: Pioneering perspectives on neurological diseases and mental illnesses. Biomedicines. 2024;12(5):1083. doi:10.3390/biomedicines12051083
  98. Wei X, Iao WC, Zhang Y, Lin Z, Lin H. Retinal microvasculature causally affects the brain cortical structure: A Mendelian randomization study. Ophthalmol Sci. 2024;4(6):100465. doi:10.1016/j. xops.2024.100465
  99. Zhan Y, Zhang Z, Lin S, et al. Causal association of sarcopenia-related traits with brain cortical structure: A bidirectional Mendelian randomization study. Aging Clin Exp Res. 2025;37(1):57. doi:10.1007/s40520-025-02977-x
  100. Kalinowska S, Trześniowska-Drukała B, Safranow K, et al. Association between thyroid function and metabolic syndrome in male and female schizophrenia patients. Psychiatry Res. 2019;274:167–175. doi:10.1016/j.psychres.2019.02.029